D.E. Shaw & Co’s Estrella Immunopharma Warrant ESLAW Stock Holding History

D.E. Shaw & Co’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.13K	Hold	87,500	–	–	﹤0.01%	4432
2025 Q4	$4.38K	Hold	87,500	–	–	﹤0.01%	4531
2025 Q3	$4.55K	Hold	87,500	–	–	﹤0.01%	4485
2025 Q2	$3.81K	Hold	87,500	–	–	﹤0.01%	4284
2025 Q1	$6.74K	Hold	87,500	–	–	﹤0.01%	4150
2024 Q4	$7.69K	Hold	87,500	–	–	﹤0.01%	4290
2024 Q3	$6.13K	Hold	87,500	–	–	﹤0.01%	4410
2024 Q2	$6.93K	Hold	87,500	–	–	﹤0.01%	4343
2024 Q1	$6.05K	Hold	87,500	–	–	﹤0.01%	4205
2023 Q4	$4.26K	Hold	87,500	–	–	﹤0.01%	4188
2023 Q3	$21K	Hold	87,500	–	–	﹤0.01%	3981
2023 Q2	$3.45K	Hold	87,500	–	–	﹤0.01%	4133
2023 Q1	$12.1K	Hold	87,500	–	–	﹤0.01%	4208
2022 Q4	$4.55K	Hold	87,500	–	–	﹤0.01%	4692
2022 Q3	$6K	Hold	87,500	–	–	﹤0.01%	4995
2022 Q2	$27K	Hold	87,500	–	–	﹤0.01%	4953
2022 Q1	$20K	Hold	87,500	–	–	﹤0.01%	5333
2021 Q4	$44K	Hold	87,500	–	–	﹤0.01%	5219
2021 Q3	$36K	Buy	+87,500	New	+$35.9K	﹤0.01%	4857

Other funds holding ESLAW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

D.E. Shaw & Co's ESLAW Position: Q1 2026 in Review

D.E. Shaw & Co held its Estrella Immunopharma Warrant (ESLAW) position steady in Q1 2026 at 87,500 shares worth $6.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4432.

D.E. Shaw & Co first reported a position in ESLAW in Q3 2021 and has held it in 19 quarters since. The position peaked at $44K in Q4 2021. 8 funds tracked by Wall St. Rank hold ESLAW as of Q1 2026.

D.E. Shaw & Co held 87,500 shares of Estrella Immunopharma Warrant worth $6.13K as of Q1 2026.
D.E. Shaw & Co left its Estrella Immunopharma Warrant share count unchanged in Q1 2026.
Estrella Immunopharma Warrant made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4432 holding.
D.E. Shaw & Co first reported a position in Estrella Immunopharma Warrant in Q3 2021 and has held it in 19 quarters since.
D.E. Shaw & Co's Estrella Immunopharma Warrant position peaked at $44K in Q4 2021.
8 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.